Market Tracker

01/16 5:15pm ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

370.21
Delayed Data
As of 4:00pm ET
 +3.25 / +0.89%
Today’s Change
340.09
Today|||52-Week Range
543.55
-1.53%
Year-to-Date
Can Biotech Keep Last Year's Momentum Alive in 2018?
Jan 11 / Zacks.com - Paid Partner Content
Stock Market News For Jan 9, 2018
Jan 09 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Celgene to Acquire Impact, J.P. Morgan Healthcare Conference i...
Jan 10 / Zacks.com - Paid Partner Content
FDA Approvals Surge in 2017: Here's a Look at the Numbers
Jan 09 / Zacks.com - Paid Partner Content
AbbVie's Upadacitinib Gains Breakthrough Therapy Designation
Jan 09 / Zacks.com - Paid Partner Content
Momenta Reports Positive Top-Line Data on Antibody M281
Jan 09 / Zacks.com - Paid Partner Content
Regeneron, Sanofi Expand Investment in Cemiplimab & Dupilumab
Jan 09 / Zacks.com - Paid Partner Content
Momenta & Mylan to Initiate Trial on Biosimilar of Eylea
Jan 04 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close366.96
Today’s open368.92
Day’s range367.35 - 374.81
Volume1,003,447
Average volume (3 months)838,724
Market cap$39.4B
Data as of 4:00pm ET, 01/16/2018

Growth & Valuation

Earnings growth (last year)+39.49%
Earnings growth (this year)+38.18%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+18.44%
P/E ratio33.6
Price/Sales8.79
Price/Book8.74

Competitors

 Today’s
change
Today’s
% change
SHPGShire-1.59-1.08%
VRTXVertex Pharmaceutica...-2.22-1.41%
BAXBaxter International...-0.67-0.98%
ALXNAlexion Pharmaceutic...+1.77+1.44%
Data as of 4:00pm ET, 01/16/2018

Financials

Next reporting dateFebruary 13, 2018
EPS forecast (this quarter)$4.49
Annual revenue (last year)$4.9B
Annual profit (last year)$895.5M
Net profit margin18.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts